1. Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease? 
Chenyang Dai, MD, Yijiu Ren, MD, Dong Xie, MD, PhD, Hui Zheng, MD, PhD, Yunlang She, MD, Ke Fei, MD, Gening Jiang, MD, Chang Chen, MD, PhD 
Journal of Thoracic Oncology 
Volume 11, Issue 10, Pages (October 2016)
DOI: /j.jtho
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Lung cancer–specific survival according to N categories in patients with NSCLC and M1a disease (A), M1a patients during 2005–2008 (B), and M1a patients during 2009–2012 (C).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Lung cancer–specific survival according to N categories in patients with malignant pleural dissemination (A), contralateral lung nodules (B), malignant pleural effusion (or pericardial effusion) (C), and malignant pleural nodules (D).
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions

4. Supplementary Figure 1
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions